Developments in RNAi, monoclonal antibodies, and more are boosting the biotech marketplace.
G. Steven Burrill
Advertisement
Chief Executive Officer at Burrill & Company
Articles by G. Steven Burrill
Advertisement
Latest Updated Articles
- Next-Generation Therapeutics on the Horizon
Published: January 2nd 2011 | Updated:
Advertisement
Advertisement
